Supriya Lifescience Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹265 - ₹274
- Lot size
- 54 shares
- Issue amount
- ₹700 cr
- Total subscription
- 0×
- Opens
- 16 Dec 2021
- Closes
- 20 Dec 2021
- Allotment
- 23 Dec 2021
- Listing
- 28 Dec 2021
Offer at a glance
Issue overview
- Issue size
- 2,55,47,445 shares
- Face value
- ₹2 Per Share
- Minimum investment
- ₹14,310
- Fresh issue
- ₹200 cr
- Offer for sale
- ₹500 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,796
- Issue type
- Bookbuilding IPO
- Shares before issue
- 7,31,83,530
- Shares after issue
- 2,55,47,445
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 54 | ₹14,796 |
| sHNI | 14 | 756 | ₹2,07,144 |
| bHNI | 68 | 3,672 | ₹10,06,128 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Company information
Company profile
Supriya Lifescience is a manufacturer of Active Pharmaceutical Ingredients (APIs), producing 38 APIs across therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatics, and anti-allergics. Between FY 2017 and FY 2021, it was the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, and one of the largest exporters of Salbutamol Sulphate in FY 2021. The company exports to 86 countries, serving 1,296 customers, including 346 distributors, across Europe, Latin America, Asia, and North America. Its modern manufacturing facility in Maharashtra spans 23,806 sq. m with a reactor capacity of 547 KL/day and seven clean rooms. Supriya Lifescience has acquired an additional 12,551 sq. m plot for expansion and holds regulatory approvals from USFDA, EDQM, TGA-Australia, KFDA-Korea, PMDA-Japan, NMPA-China, and Health Canada for its API exports.
Promoters
Satish Waman Wagh
Registrar & documents
Lead manager
ICICI Securities Limited, Axis Capital Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
207/208, Udyog Bhavan, Sonawala Road, Goregaon, East, Mumbai – 400063, Maharashtra, India
+91-22-40332727
Supriya Lifescience LimitedCompany website ↗Understanding SUPRIYA IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.